LLY Jan 2026 480.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 03:23PM EDT. Market open.
| Previous Close | 329.42 |
| Open | 175.00 |
| Bid | 324.00 |
| Ask | 332.00 |
| Strike | 480.00 |
| Expire Date | 2026-01-16 |
| Day's Range | 329.42 - 329.42 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 11 |
Zacks3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
Here we discuss three drugmakers, Eli Lilly and Company (LLY), Novo Nordisk (NVO) and Merck (MRK), that have raised their earnings as well as sales guidance for 2024.
Barrons.comRoche’s New Weight-Loss Data Shows Lilly Isn’t Unbeatable in Obesity
The results, from a small trial of a drug called CT-388, hint that Roche could be a serious player in the weight-loss market in coming years.
ZacksRoche (RHHBY) Posts Encouraging Phase I Obesity Drug Data
Data from the study shows that nearly half of the patients who received Roche's (RHHBY) subcutaneously-administered obesity drug lost more than 20% of their body weight after 24 weeks.
© 2024 Yahoo. All rights reserved.